ELAVL1 and breast carcinoma: After quantifying band intensities and normalizing them to actin, we found a strong and significant correlation between the abundance of ARID1A and HuR, supporting our findings that HuR promotes ARID1A expression in breast cancer tumors (Figure 4C,D).